June 11, 2024

RNA Analysis Market is Anticipated to Grow US$ 30.48 Bn By 2030

The global RNA Analysis market size is expected to be worth around US$ 30.48 billion by 2030, according to a new report by Vision Research Reports.

The global RNA Analysis market size was valued at US$ 10.28 billion in 2020 and is anticipated to grow at a CAGR of 14.44% during forecast period 2021 to 2030.

RNA Analysis

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39075

RNA Analysis Market Growth Factors

Technological advancements in this market can be attributed to the increasing applications of transcriptome sequencing into life science for capturing polyadenylated RNA.

The growing need for analyzing a huge number of genes to understand the gene-to-drug interactions is anticipated to enhance the application of transcriptomics technologies in discovery applications and drug development. For instance, transcriptome profiles of COVID-19 patients have been analyzed to examine the disease prognosis and management. Collaborations between research institutes for the use of transcriptomics in various applications would drive market growth.

RNA Analysis Market Report Coverage
Report Scope Details
Market Size US$ 30.48 billion by 2030
Growth Rate CAGR of 14.44% From 2021 to 2030
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Technology, Product, Application, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Agilent Technologies; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.;QIAGEN; Thermo Fisher Scientific, Inc; Eurofins Scientific; Merck KGaA; Pacific Bioscience of California, Inc; Affymetrix, Inc; Danaher Corporation; Promega

By Technology Analysis

Based on technology, real-time-PCR (qPCR) technology dominated the market with the largest revenue share of more than 56% in 2020 due to increased use of PCR for COVID-19 diagnostic across the globe.

The technology is considered to be highly sensitive and quantitative and one of the most suitable methods for interrogating a comparatively small number of transcripts in a broad set of samples. PCR offers relatively high-sensitivity detection of SARS-CoV-2, evaluation of viral RNA in various types of clinical samples, detecting SARS-CoV-2 mutations, and evaluation of anti-SARS-CoV-2 drugs.

The sequencing segment is anticipated to witness substantial growth over the forecast years owing to advancements in the next-generation and SMRT sequencing technology. The presence of several companies providing single-cell RNA sequencing services and the advent of bioinformatics algorithms are also driving the growth of this market.

By Product Analysis

Based on products, the kits & reagents segment accounted for the largest revenue share of over 58% in2020. Rising requirements for high-quality reagents and kits coupled with repeated use of reagents and media in transcriptome studies drive the segment growth.

Growing R&D activities in the pharmaceutical sector and increasing government investments in life science research are the major factors expected to fuel this market for consumables.NGS roots have begun with the adaptation of some SMART cDNA synthesis technology mainly for RNA-sequencing applications.

By Application Analysis

The Infectious diseases and pathogenesis segment accounted for a substantial market share of more than 20% in 2020 and is closely followed by alternative RNA splicing applications. Identification of susceptible cells is crucial for understanding the pathogenic mechanism.

The RNA structure and molecular dynamics segment is expected to expand at a significant CAGR from 2021 to 2028 as pharmaceutical importance for RNA in the development of a new drug is gradually growing.

By End-use Analysis

The government institutes & academic centers segment reported the highest revenue share of over 32% in 2020. The rising adoption of high throughput technologies for the effective process of RNA analysis by government institutes and academic centersis driving the segment growth.

Research in drug discovery is also contributing to the market that is followed by clinical diagnostics. For instance, in April 2021, researchers developed TORNADO-seq, an RNA sequencing-based drug discovery platform to monitor the expression of the large gene for a detailed study of cellular phenotypes in organoids.

The Italian Institute of Technology has signed a partnership agreement with European Molecular Biology Laboratory to expand their collaboration in research. This collaboration is anticipated to strengthen their database and share resources for the study.

By Regional Analysis

North America accounted for the maximum revenue share of more than 46% in 2020. The growth is attributed to the rapid development of structure-based drug designs, increasing focus on transcriptomics research, and high investment in biopharmaceutical research and development.

Growing investments by governments &enterprises are accelerating biotechnology research in Asia Pacific countries. The Japanese government and non-government organizations are highly supportive of the growth of biotechnology research in the country and provide funds to research in the fields of medicine and life sciences.

Increasing focus on Asia Pacific countries is owing to the low-cost manufacturing services, is expected to provide growth opportunities for the manufacturers.

Read also @ Unit Dose Manufacturing Market Insight and Trends 2030

Major Key Players Covered in The RNA Analysis Market Report include
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Pacific Bioscience of California, Inc.
  • Affymetrix, Inc.
  • Danaher Corporation
  • Promega
RNA Analysis Market Segmentation
  • By Technology
    • Real Time-PCR (qPCR) Technology
    • Microarray Technology
    • Sequencing Technology
    • Others
  • By Product
    • Instruments
    • Kits & Reagents
      • miRNA & siRNA
      • Reverse Transcriptases & RT-PCR
      • RNA Extraction & Purification
      • RNA Interference
      • Others
    • Services
  • By Application
    • Construction of RNA Expression Atlas
    • Epigenetics
    • Infectious Diseases and Pathogenesis
    • Alternative RNA Splicing
    • RNA Structure & Molecular Dynamics
    • Development & Delivery of RNA Therapeutics
    • Others
  • By End-use
    • Government Institutes & Academic Centers
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Hospitals & Clinics
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Italy
      • Spain
      • France
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa
      • Saudi Arabia

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Application Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global RNA Analysis Market, By Technology

7.1.  RNA Analysis Market, by Technology, 2021-2030

7.1.1.    Real Time-PCR (qPCR) Technology

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Microarray Technology

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Sequencing Technology

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global RNA Analysis Market, By Product

8.1.  RNA Analysis Market, by Product, 2021-2030

8.1.1.    Instruments

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Kits & Reagents

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Services

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global RNA Analysis Market, By Application

9.1.  RNA Analysis Market, by Application, 2021-2030

9.1.1.    Construction of RNA Expression Atlas

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Epigenetics

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Infectious Diseases and Pathogenesis

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Alternative RNA Splicing

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    RNA Structure & Molecular Dynamics

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Development & Delivery of RNA Therapeutics

9.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global RNA Analysis Market, By End-use

10.1.        RNA Analysis Market, by End-use, 2021-2030

10.1.1.  Government Institutes & Academic Centers

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Pharmaceutical & Biotechnology Companies

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Contract Research Organizations (CROs)

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Hospitals & Clinics

10.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global RNA Analysis Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.1.2.  Market Revenue and Forecast, by Product (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.2.2.  Market Revenue and Forecast, by Product (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.3.2.  Market Revenue and Forecast, by Product (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.4.2.  Market Revenue and Forecast, by Product (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.5.2.  Market Revenue and Forecast, by Product (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12.  Company Profiles

12.1.              Agilent Technologies, Inc.

12.1.1.  Company Overview

12.1.2.  Technology Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              F. Hoffmann-La Roche AG

12.2.1.  Company Overview

12.2.2.  Technology Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Illumina, Inc.

12.3.1.  Company Overview

12.3.2.  Technology Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              QIAGEN

12.4.1.  Company Overview

12.4.2.  Technology Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Thermo Fisher Scientific, Inc.

12.5.1.  Company Overview

12.5.2.  Technology Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Eurofins Scientific

12.6.1.  Company Overview

12.6.2.  Technology Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Merck KGaA

12.7.1.  Company Overview

12.7.2.  Technology Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Bio-Rad Laboratories, Inc.

12.8.1.  Company Overview

12.8.2.  Technology Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Pacific Bioscience of California, Inc.

12.9.1.  Company Overview

12.9.2.  Technology Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Affymetrix, Inc.

12.10.1.               Company Overview

12.10.2.               Technology Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39075

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Leave a Reply

Your email address will not be published. Required fields are marked *